Latest Schedule 13G passive stakes

Valor Equity Partners and associated entities have filed a Schedule 13G reporting beneficial ownership of 11.7% of BitGo Holdings, Inc. Class A common stock.

The Mack Group has filed an amendment to their Schedule 13G, reporting a total divestment of their beneficial ownership in Veris Residential, Inc.

Millennium Management LLC and Israel A. Englander have reported a 5.4% beneficial ownership stake in MacroGenics, Inc. via a Schedule 13G filing.

Bank of America Corporation and Bank of America N.A. have reported a 0% beneficial ownership stake in Eaton Vance Senior Income Trust following a successful tender offer.

Bank of America Corporation and Bank of America N.A. have reported a 0% beneficial ownership stake in Eaton Vance Senior Income Trust following a successful tender offer.

Bank of America has reported a 0% beneficial ownership in Eaton Vance Senior Floating-Rate Trust's Auction Rate Preferred shares following a tender offer.

Bank of America has reported a 0% beneficial ownership in Eaton Vance Senior Floating-Rate Trust's Auction Rate Preferred shares following a tender offer.

ADAR1 Capital Management and Daniel Schneeberger have reported a 24.1% beneficial ownership stake in InMed Pharmaceuticals, Inc.

S.H.N. Financial Investments Ltd. has filed a Schedule 13G reporting a 9.99% beneficial ownership stake in Zhongchao Inc. Class A ordinary shares.

L1 Capital Global Opportunities Master Fund, Ltd. has filed a Schedule 13G reporting a 9.99% beneficial ownership stake in HiTek Global Inc.

ADAR1 Capital Management and Daniel Schneeberger have reported a 17.5% beneficial ownership stake in Rallybio Corporation.

Linden Advisors and associated entities have filed a Schedule 13G reporting an 8.7% beneficial ownership stake in Lionheart Holdings.

Merus Global Investments, LLC has filed a Schedule 13G reporting a 5.3% beneficial ownership stake in Bleichroeder Acquisition Corp. II.

Morgan Stanley has filed an amendment indicating it no longer beneficially owns more than five percent of Terns Pharmaceuticals, Inc. common stock.

Morgan Stanley has filed an amendment indicating it no longer beneficially owns more than five percent of Terns Pharmaceuticals, Inc. common stock.

Verbena Value LP and Aaron Diamond have filed a Schedule 13G reporting a 6.21% beneficial ownership stake in Hennessy Capital Investment Corp. VII.

Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.3% beneficial ownership stake in Insight Enterprises, Inc.

Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.3% beneficial ownership stake in Insight Enterprises, Inc.

Individual investor Zhang Xin has filed a Schedule 13G reporting a 9.85% beneficial ownership stake in EUDA Health Holdings Ltd.

Versa Capital Management and associated entities have reported a zero percent beneficial ownership stake in Picard Medical, Inc.

Morgan Stanley has filed an amendment to its Schedule 13G, reporting that it no longer beneficially owns more than five percent of Apellis Pharmaceuticals common stock.

Morgan Stanley has filed an amendment to its Schedule 13G, reporting that it no longer beneficially owns more than five percent of Apellis Pharmaceuticals common stock.

MetLife Investment Management, LLC has filed a Schedule 13G reporting beneficial ownership of 100% of the Series A Mandatory Redeemable Preferred Shares of Angel Oak Financial Strategies Income Term Trust.

Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.1% beneficial ownership stake in Blackbaud Inc.

Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.1% beneficial ownership stake in Blackbaud Inc.

Global X Management Company LLC has reported a 10.16% beneficial ownership stake in Titan Machinery Inc. via a Schedule 13G filing.

Morgan Stanley has filed a Schedule 13G reporting a 10% beneficial ownership stake in Aurora Innovation, Inc. Class A common stock.

Morgan Stanley has filed a Schedule 13G reporting a 10% beneficial ownership stake in Aurora Innovation, Inc. Class A common stock.

Karpus Management, Inc. has filed a Schedule 13G reporting beneficial ownership of 11.93% of Tavia Acquisition Corp. common stock.

Karpus Management, Inc. has filed an amendment to its Schedule 13G, reporting a 0% beneficial ownership stake in SIM Acquisition Corp. I.